Related references
Note: Only part of the references are listed.Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update
Eskandar Taghizadeh et al.
BIOCHEMICAL GENETICS (2022)
Current Management Guidelines on Hyperlipidemia: The Silent Killer
Lilly Su et al.
Journal of Lipids (2021)
Lipid-lowering therapies: Better together
Maciej Banach et al.
ATHEROSCLEROSIS (2021)
The Effect of Statins in Children and Adolescents With Familial Hypercholesterolemia: A Systematic Review
Sarah Dombalis et al.
JOURNAL OF PEDIATRIC HEALTH CARE (2021)
Novel therapies for familial hypercholesterolemia
Farzahna Mohamed et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2021)
Novel Nanoparticle Biomaterial of Alginate/Chitosan Loading Simultaneously Lovastatin and Ginsenoside RB1: Characteristics, Morphology, and Drug Release Study
Quan Vo-An et al.
INTERNATIONAL JOURNAL OF POLYMER SCIENCE (2021)
Probing the particle shape effects on the biodistribution and antihyperlipidemic efficiency for oral lovastatin nanocrystals
Mengran Guo et al.
JOURNAL OF MOLECULAR LIQUIDS (2021)
Exploring the Solvent-Anti-solvent Method of Nanosuspension for Enhanced Oral Bioavailability of Lovastatin
Archana S. Patil et al.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study
Hagar B. Abo-zalam et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Hyperlipidemia: A Review of the Novel Methods for the Management of Lipids
Kosisochukwu J. Ezeh et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Expatiating the Therapeutic Profile of Garlic (Allium sativum): a Bench to Bedside Approach
Neelam Sharma et al.
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY (2021)
Satin therapy increases lipoprotein(a) levels
Sotirios Tsimikas et al.
EUROPEAN HEART JOURNAL (2020)
Worldwide burden of LDL cholesterol: Implications in cardiovascular disease
Camilla Mattiuzzi et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation
Joshua K. Beverly et al.
JOURNAL OF DIABETES (2020)
Atorvastatin-loaded nanosprayed chitosan nanoparticles for peripheral nerve injury
Mohammad Karim Haidar et al.
BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS (2020)
Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
Mona G. Arafa et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles
Fawaz N. S. Al-Heibshy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo
Hoang Thai et al.
SCIENTIFIC REPORTS (2020)
Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Anti-inflammatory Efficacy
Germeen N. S. Girgis
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2020)
Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity
Tarek A. Ahmed
BMC PHARMACOLOGY & TOXICOLOGY (2020)
Effects of nanoparticle-mediated delivery of pitavastatin on atherosclerotic plaques in ApoE-knockout mice and THP-1-derived macrophages
Yujiao Sun et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Low-density lipoprotein cholesterol lowering treatment: the current approach
Irina Crismaru et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Response surface optimization of biocompatible elastic nanovesicles loaded with rosuvastatin calcium: enhanced bioavailability and anticancer efficacy
Ibrahim Elsayed et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Clinical Pharmacology of Statins: an Update
Nicola Ferri et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins
Takeshi Hirota et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation
Dalia A. Gaber
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Preparation and optimization of pravastatin-naringenin nanotransfersomes to enhance bioavailability and reduce hepatic side effects
Khaled M. Hosny et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy
Leinys S. Santos-Baez et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
Tarek M. Faris et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
Formulation, Development and Characterization of Ethosomes of Atorvastatin
Shivendra Agarwal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION (2020)
Preparation and Evaluation of Rosuvastatin Calcium Nanosuspension and Solid Dispersion Tablets by Wet Granulation and Direct Compression Techniques using Tamarind Gum as a Binder
S. Arjun et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Incorporation of rosuvastatin-loaded chitosan/chondroitin sulfate nanoparticles into a thermosensitive hydrogel for bone tissue engineering: preparation, characterization, and cellular behavior
Mahboubeh Rezazadeh et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2019)
Fabrication of rosuvastatin-loaded polymeric nanocapsules: a promising modality for treating hepatic cancer delineated by apoptotic and cell cycle arrest assessment
Saed Aldalaen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study
Ritika Rana et al.
CURRENT MOLECULAR MEDICINE (2019)
Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model
Syed Zaki Husain Rizvi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
An overview of the bioactivity of monacolin K/lovastatin
Zixiao Xiong et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Hepatoprotective and Renoprotective Properties of Lovastatin-Loaded Ginger and Garlic Oil Nanoemulsomes: Insights into Serum Biological Parameters
Syed Ali Faran et al.
MEDICINA-LITHUANIA (2019)
Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential
Manu Sharma et al.
SCIENTIFIC REPORTS (2019)
Omega-3 Fatty Acid Based Nanolipid Formulation of Atorvastatin for Treating Hyperlipidemia
Revathy Sreedhar et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Comparative potential of Simvastatin, Rosuvastatin and Fluvastatin against bacterial infection: an in silico and in vitro study
Meenakshi Gupta et al.
ORIENTAL PHARMACY AND EXPERIMENTAL MEDICINE (2019)
Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system
S. Brito Raj et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin
Heba A. Fathi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Atorvastatin-loaded lipid nanoparticles: antitumor activity studies on MCF-7 breast cancer cells
Vaishali M. Gambhire et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Preparation and Evaluation of Mucoadhesive Nanoparticles of Rosuvastatin
Pallavi Sangave et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: Development and in vitro and in vivo evaluations
Mukundkumar Rameshbhai Hirpara et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign
Doaa H. Alshora et al.
PLOS ONE (2018)
Intranasal optimized solid lipid nanoparticles loaded in situ gel for enhancing trans-mucosal delivery of simvastatin
Tarek A. Ahmed et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2018)
Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions
Sivakumar Sudhakaran et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2018)
Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery
Divya Suares et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation
Narendar Dudhipala et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Urbanization, mainly rurality, but not attitude is associated with dyslipidemia profiles
Maria Lazo-Porras et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study
Mai Mahmoud Gabr et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Novel surface-engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor targeting: a Quality by Design-driven perspective
Sarwar Beg et al.
NANOMEDICINE (2017)
Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
Ted Okerson et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
Mohammed Elmowafy et al.
DRUG DELIVERY (2017)
The multifunctional synergistic effect of chitosan on simvastatin loaded nanoparticulate drug delivery system
N. Selvasudha et al.
CARBOHYDRATE POLYMERS (2017)
Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation
Saba Khan et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2016)
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol
Changting Xiao et al.
DIABETES (2016)
Rosuvastatin Loaded Nanostructured Lipid Carrier: For Enhancement of Oral Bioavailability
Anand Panchakshari Gadad et al.
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH (2016)
PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles
Iman S. Ahmed et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Pravastatin-loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies
Mohamed M. Badran et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2016)
Potential of novel drug delivery strategies for the treatment of hyperlipidemia
Mahima Mathur et al.
JOURNAL OF DRUG TARGETING (2016)
Familial Hypercholesterolemia Now Part of Cardiovascular Disease Genetic Epidemiology Research
Samuel S. Gidding
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Improved intestinal lymphatic drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium
Sarwar Beg et al.
RSC ADVANCES (2016)
Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia
Kritika Sharma et al.
DRUG DELIVERY (2016)
Lovastatin production: From molecular basis to industrial process optimization
Kelly C. L. Mulder et al.
BIOTECHNOLOGY ADVANCES (2015)
Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy
Mallesh Kurakula et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: Development, characterization and pharmacokinetic assessments
Saadia Ahmed Tayel et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Pitavastatin-containing nanoemulsions: Preparation, characterization and in vitro cytotoxicity
Yucel Baspinar et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2015)
Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers
Jun Zhou et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Biomarkers for Cholesterol Absorption and Synthesis in Hyperlipidemic Patients: Role for Therapeutic Selection
Alan N. B. Wu
CLINICS IN LABORATORY MEDICINE (2014)
Adipose tissue regulates hepatic cholesterol metabolism via adiponectin
Yu Li et al.
LIFE SCIENCES (2014)
Simvastatin nanoemulsion for improved oral delivery: design, characterisation, in vitro and in vivo studies
Sandip S. Chavhan et al.
JOURNAL OF MICROENCAPSULATION (2013)
The genetics of familial combined hyperlipidaemia
Martijn C. G. J. Brouwers et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Pitavastatin: An overview
Yasushi Saito
ATHEROSCLEROSIS SUPPLEMENTS (2011)
Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient
Gerald F. Watts et al.
HEART (2011)
STUDIES ON ANTIBACTERIAL, CYTOTOXIC AND ANTIOXIDANT PROPERTIES OF THE SEEDS AND LEAVES OF FICUS RACEMOSA
Salman Bin Hosain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2011)
Emerging drugs for hyperlipidemia
Christos Paras et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
EVALUATION OF ANTIOXIDANT POTENTIAL OF TINOSPORA CORDIFOLIA AND TINOSPORA SINENSIS
Sanjay Jain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2010)
HYPOGLYCEMIC EFFECTS OF METHANOLIC EXTRACT OF ANTHOCEPHALUS CADAMBA BARK IN ALLOXAN INDUCED DIABETIC RATS (ROX B) MIQ.
Himanshu Gurjar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2010)
Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia
Antonio M. Gotto et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors
Evelyn Orso et al.
ATHEROSCLEROSIS SUPPLEMENTS (2009)
Secondary stroke prevention in the elderly: New evidence in hypertension and hyperlipidemia
Luis Castilla-Guerra et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Management of hyperlipidemias: An update
Nitin Ranjan
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
Microbial production and biomedical applications of lovastatin
R Aravindan et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Management of Hyperlipidemia in Older Adults
Karen P. Alexander et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Pravastatin: an evidence-based statin?
Antonio Iglesias del Sol et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Primary hyperlipidemia
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
Hypercholesterolaemia and its management
Deepak Bhatnagar et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
The biology and chemistry of hyperlipidemia
Kishor S. Jain et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Cholesterol reduction yields clinical benefits: Meta-analysis including recent trials
A. Lawrence Gould et al.
CLINICAL THERAPEUTICS (2007)
Nanoparticles - a historical perspective
Joerg Kreuter
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia
LL Rudel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Simvastatin: a review
TR Pedersen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Drug treatment of hyperlipidemia in women
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
JA Tobert
NATURE REVIEWS DRUG DISCOVERY (2003)
Stroke in renal transplant recipients:: epidemiology, predictive risk factors and outcome
A Oliveras et al.
CLINICAL TRANSPLANTATION (2003)
Statins as anti-inflammatory agents
G Weitz-Schmidt
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Contemporary management of hyperlipidemia in women
LJ Mosca
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2002)
High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects
PP Toth
DM DISEASE-A-MONTH (2001)
Atorvastatin - An updated review of its pharmacological properties and use in dyslipidaemia
HS Malhotra et al.
DRUGS (2001)
Clinical pharmacokinetics of pravastatin - Mechanisms of pharmacokinetic events
T Hatanaka
CLINICAL PHARMACOKINETICS (2000)
Share Paper
